Claritev

Claritev Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Claritev (CTEV) as of Oct 26, 2026 is -372.92. In the previous year, Net Debt to Free Cash Flow Ratio was -428.87 — a change of -13.05% (higher).

Net Debt/FCF

-372.92

YoY

-13.05%

Last updated:

Net Debt to Free Cash Flow Ratio of Claritev is 2025 -372.92 . Net Debt to Free Cash Flow Ratio of Claritev was 2024 -428.87 . It decreases by -13.05% higher compared to the previous year.

The Claritev Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2019
24.67 USD
Jan 1, 2020
14.52 USD
Jan 1, 2021
14.71 USD
Jan 1, 2022
15.64 USD
Jan 1, 2023
71.17 USD
Jan 1, 2024
-428.87 USD
Jan 1, 2025
-372.92 USD
The Claritev Net Debt/FCF history
YEARNet Debt/FCFYoY
-372.92-13.05%
-428.87-702.58%
71.17+354.99%
15.64+6.38%
14.71+1.26%
14.52-41.13%
24.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Claritev Stock analysis

What does Claritev do? Claritev Corp generates revenue through its Analytics-Based Services, which uses data-driven algorithms to detect over-charges in healthcare claims and negotiate fair reimbursement for out-of-network costs. The company also offers Network-Based Services, including contracting discounts with providers to form independent PPOs and providing outsourced network development and management. Payment and Revenue Integrity Services identifies improper charges before or after claims are paid, while its SaaS platform delivers data analytics for healthcare cost management. Clients include healthcare providers, insurers, and employers seeking cost efficiency in medical billing and reimbursement processes. Claritev Corp's products target segments such as healthcare cost management, network development, and revenue integrity. The company's SaaS platform integrates descriptive, predictive, and prescriptive analytics to process data from multiple sources. Its services are designed to reduce overpayments and underpayments in healthcare claims, appealing to organizations focused on optimizing financial outcomes in medical billing. The business model relies on selling these integrated services to healthcare organizations, with a focus on data-driven solutions for cost control. Analytics-Based Services and Payment and Revenue Integrity Services directly address claim accuracy and reimbursement fairness, while Network-Based Services create cost-saving provider networks. The SaaS platform serves as the technological backbone for all offerings, enabling scalable data processing and insights. Claritev is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Claritev stock

Net Debt to Free Cash Flow Ratio of Claritev is -372.92 in 2025.

Net Debt to Free Cash Flow Ratio of Claritev changed from -428.87 to -372.92, representing a -13.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Claritev since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Claritev with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Claritev

All Key Metrics — Claritev